Dr. Mortazavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2006
- University at BuffaloResidency, Internal Medicine, 2000 - 2003
- Tehran University of Medical Sciences School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2024 - 2026
- OH State Medical License 2003 - 2026
- FL State Medical License 2019 - 2022
- PA State Medical License Active through 2012
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2017 Jul 19
Publications & Presentations
PubMed
- CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications.Sayan Mullick Chowdhury, Feng Hong, Christian Rolfo, Zihai Li, Kai He
Biology. 2025-02-18 - Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.Adam Khorasanchi, Feng Hong, Yuanquan Yang, Eric A Singer, Peng Wang
Cancer Drug Resistance. 2025-01-01 - Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.Adam Khorasanchi, Karan Jatwani, Lingbin Meng, Katharine A Collier, Debasish Sundi
Cancers. 2024-12-10
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: